Long-Term Safety and Efficacy of Drug-Eluting versus Bare-Metal Stents in Sweden
New England Journal of Medicine2009Vol. 360(19), pp. 1933–1945
Citations Over TimeTop 1% of 2009 papers
Stefan James, Ulf Stenestrand, Johan Lindbäck, J. Carlsson, Fredrik Scherstén, Tage Nilsson, Lars Wallentin, Bo Lagerqvist
Abstract
As compared with bare-metal stents, drug-eluting stents are associated with a similar long-term incidence of death or myocardial infarction and provide a clinically important decrease in the rate of restenosis among high-risk patients.
Related Papers
- → Long term outcomes in octogenarians undergoing percutaneous coronary intervention: Comparison of bare metal versus drug eluting stent(2014)17 cited
- → One year clinical outcomes in patients with chronic kidney disease treated by percutaneous coronary intervention with drug-eluting stent(2011)2 cited
- → Real world study of the clinical outcomes in the contemporary use of bare metal stents in primary PCI(2009)
- → AS-144: Impact of Age on the Percutaneous Coronary Intervention Outcomes in the Drug-Eluting Stent Era(2009)
- → TCT-31 Clinical Impact of Genetics on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention Using Drug-Eluting Stent(2022)